Ginkgolic Acid Inhibits the Invasiveness of Colon Cancer Cells Through AMPK Activation

Overview

Journal Oncol Lett

Specialty Oncology

Date 2017 Nov 9

PMID 29113214

Citations 22

Authors

Lina Qiao

Jianbao Zheng

Xianzhen Jin

Guangbing Wei

Guanghui Wang

Xuejun Sun

Xuqi Li

Affiliations

Soon will be listed here.

Abstract

Tumor cell invasion and metastasis are important processes in colorectal cancer that exert negative effects on patient outcomes; consequently, a prominent topic in the field of colorectal cancer study is the identification of safe and affordable anticancer drugs against cell invasion and metastasis, with limited side effects. Ginkgolic acid is a phenolic acid extracted from ginkgo fruit, ginkgo exotesta and ginkgo leaves. Previous studies have indicated that ginkgolic acid inhibits tumor growth and invasion in a number of types of cancer; however, limited studies have considered the effects of ginkgolic acid on colon cancer. In the present study, SW480 colon cancer cells were treated with a range of concentrations of ginkgolic acid; tetrazolium dye-based MTT, wound-scratch and transwell migration assays were performed to investigate the effects on the proliferation, migration and invasion of colon cancer cells, and potential mechanisms for the effects were explored. The results indicated that ginkgolic acid reduced the proliferation and significantly inhibited the migration and invasion of SW480 cells in a concentration-dependent manner. Additional experiments indicated that ginkgolic acid significantly decreased the expression of invasion-associated proteins, including matrix metalloproteinase (MMP)-2, MMP-9, urinary-type plasminogen activator and C-X-C chemokine receptor type 4, and activated adenosine monophosphate activated protein kinase (AMPK) in SW480 cells. Small interfering RNA silencing of AMPK expression reversed the effect of ginkgolic acid on the expression of invasion-associated proteins. This result suggested that ginkgolic acid inhibited the proliferation, migration and invasion of SW480 colon cancer cells by inducing AMPK activation and inhibiting the expression of invasion-associated proteins.

Citing Articles

Targeting deubiquitinating enzymes (DUBs) and ubiquitin pathway modulators to enhance host defense against bacterial infections.

Santelices J, Schultz A, Schultz A, Walker A, Adams N, Tirado D bioRxiv. 2025; .

PMID: 39975367 PMC: 11838268. DOI: 10.1101/2025.01.27.635188.

SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts.

Martinez-Lopez A, Infante G, Mendiburu-Elicabe M, Machuca A, Anton O, Gonzalez-Fernandez M Cell Oncol (Dordr). 2024; .

PMID: 39432155 DOI: 10.1007/s13402-024-01005-w.

Ginkgolic acid regulates myogenic development by influencing the proliferation and differentiation of C2C12 myoblast cells.

Liu H, Joung H Mol Med Rep. 2024; 30(5).

PMID: 39301652 PMC: 11413845. DOI: 10.3892/mmr.2024.13328.

Ginkgolic acid inhibits orthopneumo- and metapneumo- virus infectivity.

Luck M, Subillaga E, Borenstein R, Sabo Y Sci Rep. 2024; 14(1):8230.

PMID: 38589437 PMC: 11001990. DOI: 10.1038/s41598-024-58032-8.

A novel risk model of three SUMOylation genes based on RNA expression for potential prognosis and treatment sensitivity prediction in kidney cancer.

Li S, Yan L, Wei X, Jia Z, Yang J, Ning X Front Pharmacol. 2023; 14:1038457.

PMID: 37201027 PMC: 10185777. DOI: 10.3389/fphar.2023.1038457.

References

Oh J, Hwang I, Hong C, Lyu S, Na M . Inhibition of fatty acid synthase by ginkgolic acids from the leaves of Ginkgo biloba and their cytotoxic activity. J Enzyme Inhib Med Chem. 2012; 28(3):565-8. DOI: 10.3109/14756366.2012.658786. View

Kim J, Takeuchi H, Lam S, Turner R, Wang H, Kuo C . Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol. 2005; 23(12):2744-53. DOI: 10.1200/JCO.2005.07.078. View

Baur D, Klotsche J, Hamnvik O, Sievers C, Pieper L, Wittchen H . Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort. Metabolism. 2010; 60(10):1363-71. DOI: 10.1016/j.metabol.2010.09.012. View

Kim J, Mori T, Chen S, Amersi F, Martinez S, Kuo C . Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg. 2006; 244(1):113-20. PMC: 1570598. DOI: 10.1097/01.sla.0000217690.65909.9c. View

Lee J, Kim Y, Ryu S, Cho M, Lee J . Ginkgolic acids and Ginkgo biloba extract inhibit Escherichia coli O157:H7 and Staphylococcus aureus biofilm formation. Int J Food Microbiol. 2014; 174:47-55. DOI: 10.1016/j.ijfoodmicro.2013.12.030. View

Brandi G, De Lorenzo S, Nannini M, Curti S, Ottone M, DallOlio F . Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis. World J Gastroenterol. 2016; 22(2):519-33. PMC: 4716056. DOI: 10.3748/wjg.v22.i2.519. View

Kuhajda F . AMP-activated protein kinase and human cancer: cancer metabolism revisited. Int J Obes (Lond). 2008; 32 Suppl 4:S36-41. PMC: 7104469. DOI: 10.1038/ijo.2008.121. View

Li J, Yu L, Shen Y, Zhou L, Wang Y, Zhang J . Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro. World J Gastroenterol. 2008; 14(15):2308-13. PMC: 2705083. DOI: 10.3748/wjg.14.2308. View

Fukuda I, Ito A, Hirai G, Nishimura S, Kawasaki H, Saitoh H . Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate. Chem Biol. 2009; 16(2):133-40. DOI: 10.1016/j.chembiol.2009.01.009. View

10.

Schimanski C, Schwald S, Simiantonaki N, Jayasinghe C, Gonner U, Wilsberg V . Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res. 2005; 11(5):1743-50. DOI: 10.1158/1078-0432.CCR-04-1195. View

11.

Li X, Ma Q, Xu Q, Liu H, Lei J, Duan W . SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway. Cancer Lett. 2012; 322(2):169-76. PMC: 3408048. DOI: 10.1016/j.canlet.2012.02.035. View

12.

Schmittgen T, Livak K . Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3(6):1101-8. DOI: 10.1038/nprot.2008.73. View

13.

Ioannou G, Boyko E . Metformin and colorectal cancer risk in diabetic patients. Diabetes Care. 2011; 34(10):2336-7. PMC: 3177744. DOI: 10.2337/dc11-1447. View

14.

Smith J, Deane N, Wu F, Merchant N, Zhang B, Jiang A . Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology. 2009; 138(3):958-68. PMC: 3388775. DOI: 10.1053/j.gastro.2009.11.005. View

15.

Yu Q, Qiu H, Zhang M, Hu G, Liu B, Huang L . Predictive effects of bilirubin on response of colorectal cancer to irinotecan-based chemotherapy. World J Gastroenterol. 2016; 22(16):4250-8. PMC: 4837442. DOI: 10.3748/wjg.v22.i16.4250. View

16.

DeCensi A, Puntoni M, Goodwin P, Cazzaniga M, Gennari A, Bonanni B . Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res (Phila). 2010; 3(11):1451-61. DOI: 10.1158/1940-6207.CAPR-10-0157. View

17.

Abad A, Massuti B, Anton A, Vega M, Yuste A, Marcuello E . Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II study. Acta Oncol. 2007; 47(2):286-92. DOI: 10.1080/02841860701630259. View

18.

Montales M, Simmen R, Ferreira E, Neves V, Simmen F . Metformin and soybean-derived bioactive molecules attenuate the expansion of stem cell-like epithelial subpopulation and confer apoptotic sensitivity in human colon cancer cells. Genes Nutr. 2015; 10(6):49. PMC: 4623856. DOI: 10.1007/s12263-015-0499-6. View

19.

Sung J, Ng S, Chan F, Chiu H, Kim H, Matsuda T . An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut. 2014; 64(1):121-32. DOI: 10.1136/gutjnl-2013-306503. View

20.

Guo F, Wang Y, Liu J, Mok S, Xue F, Zhang W . CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks. Oncogene. 2015; 35(7):816-26. DOI: 10.1038/onc.2015.139. View